Kiora Pharmaceuticals(KPRX.US)

Last Updated 19:00:00 ET
longbridge loading

Kiora Pharmaceuticals Inc 1Q 2026: Revenue ($2.4M), Net income ($2.42M), EPS ($0.58) — 10-Q Summary

TradingView·
US
KPRX
+0.40%
US
FBT
+0.54%
US
ARKG
+0.04%
TradingView·
US
KPRX
+0.40%
US
FBT
+0.54%
US
ARKG
+0.04%

Kiora Pharmaceuticals | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
KPRX
+0.40%
Earnings Watch·
US
KPRX
+0.40%

Kiora Pharmaceuticals | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
KPRX
+0.40%
Earnings Watch·
US
KPRX
+0.40%

Kiora Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update | KPRX Stock News

StockTitan·
US
KPRX
+0.40%
US
IBB
+0.10%
US
PBE
+0.11%
StockTitan·
US
KPRX
+0.40%
US
IBB
+0.10%
US
PBE
+0.11%

12 Health Care Stocks Moving In Monday's After-Market Session

benzinga_article·
US
SANA
+0.66%
US
KPRX
+0.40%
US
CUE
-5.05%
benzinga_article·
US
SANA
+0.66%
US
KPRX
+0.40%
US
CUE
-5.05%

12 Health Care Stocks Moving In Wednesday's Intraday Session

benzinga_article·
US
IBB
+0.10%
US
ARKG
+0.04%
US
QNCX
+7.56%
benzinga_article·
US
IBB
+0.10%
US
ARKG
+0.04%
US
QNCX
+7.56%

U.S. stock market midday update: Kiora Pharmaceuticals financing news sparks market enthusiasm, stock price surges 19.76%!

Price Alert·
US
KPRX
+0.40%
Price Alert·
US
KPRX
+0.40%

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

benzinga_article·
US
PFSA
-7.31%
US
KPRX
+0.40%
US
CUPR
-3.21%
benzinga_article·
US
PFSA
-7.31%
US
KPRX
+0.40%
US
CUPR
-3.21%

Kiora Pharmaceuticals shares are trading higher after the company announced it will sell up to 438,471 shares in a private placement.

benzinga_article·
US
KPRX
+0.40%
US
LABU
-2.35%
US
BBH
+0.68%
benzinga_article·
US
KPRX
+0.40%
US
LABU
-2.35%
US
BBH
+0.68%

Kiora Pharmaceuticals Announces $5 Million Private Placement Financing

Tip Ranks·
US
FBT
+0.54%
US
LABU
-2.35%
US
BBH
+0.68%
Tip Ranks·
US
FBT
+0.54%
US
LABU
-2.35%
US
BBH
+0.68%
© 2026 Longbridge｜Disclaimer